Transcription mesosome Med23 subunit serving as target for preventing or treating cancer
A subunit and gene technology, applied in the field of cancer prevention or treatment, can solve the problems of low chemotherapy efficiency, lost operation opportunities, and severe toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0102] Loss of Med23 slows down the growth rate of A549 cells and weakens the tumorigenic ability of A549 cells in vitro and in vivo
[0103] Experimental method: Using the expression of Med23 in retrovirus-based RNAi knockdown A549 cells (a non-small cell lung cancer cell line, which contains activating K-ras mutation), the cells of RNAi and control A549 cells were counted. The results showed that after knockdown Med23, the growth rate of A549 cells was significantly slower, indicating that Med23 was involved in the process of regulating the growth of A549 cells ( figure 1 B).
[0104] At the same time, Soft Agar Colony Formation Assay was performed on RNAi and control A549 cells, and it was found that the tumorigenic ability of A549 cells with RNAi Med23 was significantly weakened. The number and diameter of colony formed by the two were counted, and it was found that the colony formed by Knockdown cells was smaller than that of A549 cells. less, and very small and loose ( ...
Embodiment 2
[0108] Deletion of Med23 significantly reduces the efficiency of Oncogene Ras transformation into immortalized MEFs
[0109] It is known that Oncogene ras can transform immortalized MEFs in vitro, and the transformed MEFs will lose contact inhibition and be able to grow in suspension in soft agar to form clones, and eventually form tumors in nude mice subcutaneously. This example attempts to detect whether Med23 causes the above phenomenon by affecting ras.
[0110] It was found that the efficiency of Ras transforming Med23- / - MEF cells was greatly reduced compared with the wild type, and the number and size of clones formed ( figure 2 B. figure 2 C), and the subcutaneous tumorigenic ability of nude mice was significantly inferior to that of WT MEF cells ( figure 2 D), indicating that the loss of Med23 affects the process of Oncogene ras transformation.
Embodiment 3
[0112] Deletion of Med23 has no significant effect on the efficiency of Oncogene c-myc to transform immortalized MEFs
[0113] Different from ras transformation, the inventors found that the efficiency of c-myc transforming Med23- / - MEF cells was not significantly different from that of wild type, and the size and number of clones formed were similar to those of WT MEF ( image 3 C. image 3 D), indicating that the deletion of Med23 has little effect on Oncogene c-myc, thus further explaining the correlation between Med23 and Ras / MAPK signaling pathway.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com